Biotechnology
FDA Resumes Approval of Sarepta Therapeutics’ Duchenne Therapy for Younger Patients: What You Need to Know
The FDA has made a significant announcement regarding Sarepta Therapeutics’ gene therapy for Duchenne muscular dystrophy. Effective Monday, the agency ... Read more
UnitedHealth Collaborates with DOJ on Medicare Billing Practices Investigation: What You Need to Know
UnitedHealth Group is currently under investigation by the Justice Department regarding its Medicare billing practices. This comes as a significant ... Read more
Sarepta Therapeutics’ Duchenne Therapy: What an FDA Official Says About Its Challenging Road to Market
Sarepta Therapeutics is facing tough challenges with its gene therapy for Duchenne muscular dystrophy, called Elevidys. This treatment is currently ... Read more
Breaking News: Sarepta Therapeutics Suspends Duchenne Gene Therapy Shipments—What This Means for Patients
Sarepta Therapeutics announced it will stop shipments of Elevidys, a gene therapy for Duchenne muscular dystrophy, following a request from ... Read more
Sarepta Therapeutics Cuts One-Third of Workforce: What This Means for the Future of the Company
Sarepta Therapeutics has recently made significant cutbacks, laying off about 500 employees, which is more than one-third of its workforce. ... Read more
Trump’s Bold Move: Upcoming 200% Tariff on Pharmaceuticals Could Impact Your Wallet!
President Donald Trump has recently announced plans to impose tariffs of up to 200% on pharmaceuticals imported into the U.S. ... Read more
Exciting Breakthrough: Moderna’s Flu Vaccine Shines in Late-Stage Trials, Setting the Stage for a Combined COVID Vaccine
Moderna recently revealed that its new mRNA-based flu vaccine is showing promise. In late-stage trials, it triggered a stronger immune ... Read more
Revolutionary Project: Scientists Aim to Construct a Human Genome from the Ground Up
A group of researchers in the UK is breaking new ground by working on creating artificial human DNA from scratch. ... Read more
